2019-nCoV Outbreak and Cardiovascular Diseases

February 3, 2020 updated by: Pan-Pan Hao, Qilu Hospital of Shandong University

Impact of a Novel Coronavirus (2019-nCoV) Outbreak on Public Anxiety and Cardiovascular Disease Risk in China

Cardiovascular events occurring after 2019-nCoV outbreak in Jinan were prospectively assessed by emergency physicians. We compared those events with events that occurred during the past 3 months and the same months of the last year.

Study Overview

Status

Unknown

Conditions

Detailed Description

This survey aims to assess whether the public anxiety from a novel coronavirus (2019-nCoV) outbreak increases cardiovascular disease risk in China. Cardiovascular events occurring after 2019-nCoV outbreak in Jinan were prospectively assessed by emergency physicians. We compared those events with events that occurred during the past 3 months and the same months of the last year.

Study Type

Observational

Enrollment (Anticipated)

12000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • China
    • Shandong
      • Binzhou, Shandong, China
        • Recruiting
        • Affiliated Hospital of Binzhou Medical Universty
        • Contact:
          • Min Feng, MD, PhD
        • Sub-Investigator:
          • Min Feng, MD, PhD
      • Heze, Shandong, China
        • Recruiting
        • Heze Municipal Hospital
        • Contact:
          • Lujing Meng, MD
        • Sub-Investigator:
          • Lujing Meng, MD
      • Jinan, Shandong, China
        • Recruiting
        • The Second Hospital of Shandong University
        • Contact:
          • kun Wen, MD
        • Principal Investigator:
          • Kun Wen, MD
        • Sub-Investigator:
          • Xuexi Hao, MD
      • Jinan, Shandong, China, 250012
        • Recruiting
        • Shandong University Qilu Hospital
        • Contact:
        • Sub-Investigator:
          • Yanping Liu, MD
      • Jinan, Shandong, China, 250013
        • Recruiting
        • Jinan Central Hospital, Shandong University
        • Contact:
        • Sub-Investigator:
          • Peixin Hu, MD
        • Principal Investigator:
          • Bin Li, MD, PhD
      • Jinan, Shandong, China, 250014
        • Recruiting
        • First Hospital Affiliated with Shandong First Medical University
        • Contact:
      • Jinan, Shandong, China, 250021
        • Recruiting
        • Shandong Provincial Hospital, Shandong University
        • Sub-Investigator:
          • Xin Zhang, MD
        • Contact:
          • Xin Zhang, MD
      • Jining, Shandong, China
        • Recruiting
        • Jining Hospital of Traditional Chinese Medicine
        • Contact:
          • Zhengyan Qu, MD
        • Sub-Investigator:
          • Zhengyan Qu, MD
      • Qihe, Shandong, China
        • Recruiting
        • Qihe People's Hospital
        • Contact:
          • Jianjun Lu, MD
        • Sub-Investigator:
          • Jianjun Lu, MD
      • Qingdao, Shandong, China, 266003
        • Recruiting
        • Affiliated Hospital of Qingdao University Medical College
        • Contact:
          • Liang Shan, MD
        • Sub-Investigator:
          • Liang Shan, MD
      • Weihai, Shandong, China
        • Recruiting
        • Weihai Municipal Hospital
        • Contact:
          • Lei Cao, MD
        • Sub-Investigator:
          • Lei Cao, MD
      • Zibo, Shandong, China
        • Recruiting
        • Central Hospital of Zibo
        • Contact:
          • Bo Li, MD, PhD
        • Sub-Investigator:
          • Bo Li, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients visiting emergency department.

Description

Inclusion Criteria:

  • Patients visiting emergency department.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
After outbreak
Past 3 months
Last year

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Cardiovascular Death
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Major Adverse Cardiovascular Events
Time Frame: 3 months
3 months
Times From symptom onset to hospital arrival
Time Frame: 3 months
3 months
Anxiety
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Qilu Hospital of Shandong University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2020

Primary Completion (Anticipated)

April 30, 2020

Study Completion (Anticipated)

April 30, 2020

Study Registration Dates

First Submitted

February 3, 2020

First Submitted That Met QC Criteria

February 3, 2020

First Posted (Actual)

February 5, 2020

Study Record Updates

Last Update Posted (Actual)

February 5, 2020

Last Update Submitted That Met QC Criteria

February 3, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019nCoV-CVD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Death; Major Adverse Cardiovascular Events

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe